Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Rosuvastatin and Ezetimibe FDC vs Components in Healthy Volunteers
NCT04895059Phase 1Completed
- Sponsor
- Laboratorios Silanes
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin and ezetimibe in hypercholesterolemia, sponsored by Laboratorios Silanes. Primary endpoints: Maximum observed concentration, Area under the curve from time zero to the last measurable concentration and 2 more. Started Apr 2017; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04895059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895059.